complete the following:

with this information:

Chemicals and Allied Products Industry Year 2018 Ratios Company Name: 2018 0.47 0.38 -9.43 3.47 2.12 2.24 Solvency or Debt Ratios Merck J&J Debt ratio Debt-to-equity ratio Interest coverage ratio Liquidity Ratios Current ratio Quick ratio Cash ratio Profitability Ratios Profit margin .... ROE (Return on equity), after tax ROA (Return on assets) Gross margin Operating margin (Return on sales) Activity or Efficiency Ratios Asset turnover Receivables turnover (days) Inventory turnover (days) Price Ratios Dividend Payout Ratio -93.4% -248.5 -146.5 55.3% -42.9% . 1.08 16 36 0.15 Johnson & Johnson (JNJ) Balance Sheet December 31, 2018 (Sin millions) ASSETS Current Assets Cash, cash equivalents and short-term investments $19,687 Receivables 14,098 Inventory 9.549 Other current assets 2,699 Total Current Assets: 46,033 Noncurrent Assets Property, plant and equipment, net 17,035 Net Intangible assets (including goodwill) 78,064 Other noncurrent assets 11,822 Total Noncurrent Assets: 106,921 TOTAL ASSETS: $152,954 LIABILITIES AND EQUITY Liabilities Current Liabilities Accounts Payable 7,537 Accrued liabilities 11,517 Short term debt 2,800 Other noncurrent liabilities 9,376 Total current liabilities: 31,230 Noncurrent Liabilities Long-term debt and lease obligation 27.684 Liabilities, other than long-term debt (pension, deferred tax, other) 34,288 Total noncurrent liabilities: 61,972 TOTAL LIABILITIES: 93,202 Stockholders'equity Common stock 3.120 Treasury stock, value -34,362 Accumulated other comprehensive loss -15,222 Retained earnings 106,216 Total stockhholders'equity 59,752 Total Liabilities and Stockholders'Equity: $152,954 Merck & Company, Inc. (MRK) Balance Sheet December 31, 2018 (S in millions) ASSETS Current Assets Cash, cash equivalents and short-term investments $8,8641 Receivables 7,071 Inventory 5,440 Other current assets 4,500 Total Current Assets: 25,875 Noncurrent Assets Property, plant and equipment, net 13,291 Net Intangible assets (including goodwill) 29,684 Other noncurrent assets 13,787 Total Noncurrent Assets: 56,762 TOTAL ASSETS: $82,637 LIABILITIES AND EQUITY Liabilities Current Liabilities Accounts Payable 3,318 Accrued liabilities 3,429 Short term debt 5,308 Other noncurrent liabilities 10,151 Total current liabilities: 22,206 Noncurrent Liabilities Long-term debt and lease obligation 19,806 Liabilities, other than long-term debt (pension, defferred tax, other) 13,743 Total noncurrent liabilities: 33,549 TOTAL LIABILITIES: 55,755 Stockholders'equity Common stock 1,7881 Treasury stock, value -50,929 Additional paid in capital 38,808 Accumulated other comprehensive loss -5,545 Retained earnings 42,579 Stockholders'equity attributable to noncontrolling interest 181 Total stockhholders'equity 26,882 Total Liabilities and Stockholders'Equity: $82,637 Merck & Company, Inc. (MRK) Income Statement For period ending December 31, 2018 (Sin millions) Revenues Revenues, net S42,294 Cost of Revenue -13,509 Gross profit: 28,785 Operating Expenses -20.486 Operating Income: 8,299 Nonoperating income (expense) 402 Interest and debt expense -7721 Other undisclosed income (loss) from continuing operations before income taxes: 772 Income from continuing operations before income taxes: 8,701 Income tax expense -2,508 Net Income available to stockholder $6,193 Dividends paid to Stockholders -5,172 Retained Earnings $1,021 Johnson & Johnson (JNJ) Income Statement For period ending December 31, 2018 ($ in millions) Revenues Revenues, net $81,581 Cost of Revenue -27,091 Gross profit: 54,490 Operating Expenses -34,692 Operating Income: 19,798 Nonoperating income (expense) -794 Interest and debt expense -1,005 Income from continuing operations before income taxes: 17,999 Income tax expense -2,702 Net Income available to stockholder $15,297 Dividends paid to Stockholders -9,494 Retained Earnings $5,803